All News

    Gene Variant May Predict Side Effects From Kidney Cancer Immunotherapy

    May 27th 2025, 8:00pm

    Video

    A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy.

    Improving Education and Advocacy in Waldenström Macroglobulinemia

    May 27th 2025, 7:00pm

    Article

    Education and patient advocacy are essential to improving care in Waldenström macroglobulinemia amid clinical advances, according to Dr. Shirley D'Sa.

    Connecting With Nature After Colon Cancer: My Self-Care Practices

    May 27th 2025, 5:00pm

    Article

    Connecting with nature through journaling, walking and meditation helped me heal during and after colon cancer treatment.

    Dose Escalation Complete in Kidney Cancer Trial of HC-7366 Plus Welireg

    May 27th 2025, 4:00pm

    Article

    A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation portion of the clinical trial.

    First Patient Dosed in MORNINGSTAR Trial of Mavrostobart for Solid Tumors

    May 27th 2025, 3:00pm

    Article

    The first patient has received treatment with mavrostobart plus chemo in the phase 1/2 MORNINGSTAR trial for advanced solid tumors, including lung cancer.

    How Essential Thrombocythemia and Polycythemia Vera Affect Blood Flow

    May 27th 2025, 1:00pm

    Video

    Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used.

    What I Would Tell the Woman I Was Before Breast Cancer

    May 26th 2025, 7:00pm

    Article

    After being diagnosed with breast cancer at 39, I learned to advocate for myself, transforming fear into fierce resolve and purpose through every step.

    Finding Peace Beyond Caregiving and Oncology

    May 26th 2025, 5:00pm

    Article

    I reflect on my journey from caregiver to advocate, embracing a future shaped by cancer but no longer defined by it.

    Understanding Unique Challenges AYA Patients With Cancer Face

    May 26th 2025, 1:00pm

    Article

    Dr. Andrew M. Evens discusses long-term survivorship challenges that can occur among adolescent and young lymphoma survivors.

    IDH Inhibitors Offer New, Safer Option for Some Brain Tumors

    May 25th 2025, 6:00pm

    Video

    IDH inhibitors, now FDA approved for lower-grade gliomas, yield fewer side effects than chemotherapy, said Dr. Ryan Merrell.